Immunotherapy
Exploring immune checkpoint inhibitors, equivalent to nivolumab and different osteosarcoma therapies, is a superb encouragement. Early research point out that immunotherapy might considerably enhance outcomes for kids with osteosarcoma, inspiring hope within the medical group and the households of those younger sufferers.
